drugset / Trial / NCT03137784
Bronchodilator Effects and Safety of Glycopyrronium Bromide (25 ug and 50 ug o.d.) in Asthma
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this trial is to characterize the bronchodilator effects and safety of 25 ug and 50 ug o.d. NVA237 (glycopyrronium bromide) doses compared to placebo in asthma patients
Timeline
- Start
- 2017-05-04
- Primary completion
- 2017-12-29
- Completion
- 2017-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glycopyrrolate | Small molecule | 25 ug | — |
| Subject | Glycopyrrolate | Small molecule | 50 ug | — |